MEDX:NSD-Horizon Kinetics Medical ETF (USD)

ETF | Others |

Last Closing

USD 28.699

Change

+0.13 (+0.45)%

Market Cap

N/A

Volume

500.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-25 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

-3.38 (-6.33%)

USD 59.02B
QQQM Invesco NASDAQ 100 ETF

-2.67 (-1.25%)

USD 42.88B
JEPQ JPMorgan Nasdaq Equity Premium..

-0.62 (-1.09%)

USD 22.89B
ACWI iShares MSCI ACWI ETF

-0.19 (-0.16%)

USD 19.98B
CGABL The Carlyle Group Inc. 4.625% ..

+0.19 (+1.06%)

USD 16.14B
NVDL GraniteShares 1.5x Long NVDA D..

-3.16 (-5.58%)

USD 4.90B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.01 (+0.01%)

USD 4.81B
TSLL Direxion Shares ETF Trust - Di..

-2.92 (-16.85%)

USD 4.32B
ETHA iShares Ethereum Trust ETF

-1.16 (-5.80%)

USD 3.75B
USCL iShares Climate Conscious & Tr..

-0.30 (-0.42%)

USD 2.33B

ETFs Containing MEDX

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.83% 90% A- 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.83% 90% A- 82% B
Trailing 12 Months  
Capital Gain -5.72% 22% F 44% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.72% 20% F 43% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -0.16% 37% F 38% F
Dividend Return -0.16% 30% F 34% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 3.16% 88% B+ 97% N/A
Risk Adjusted Return -5.19% 29% F 31% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector